The disclosure provides monoamine neurotransmitter releaser and/or monoamine uptake inhibitor compounds having biogenic amine transporter activity but lacking substantial activity at 5-HT2 receptor subtypes. The phenethylamine or vinylogous phenethylamine compounds of the disclosure are useful in treating diseases, conditions and/or disorders mediated by activity of one or more of the monoamine neurotransmitters.
该披露提供了具有
生物胺转运体活性但在5-HT2受体亚型上缺乏显著活性的单胺神经递质释放剂和/或单胺摄取
抑制剂化合物。该披露的苯
乙胺或亲缘苯
乙胺化合物在治疗由一个或多个单胺神经递质活性介导的疾病、状况和/或障碍方面是有用的。